Conditional deletion of neurexins dysregulates neurotransmission from dopamine neurons

  1. Charles Ducrot
  2. Gregory de Carvalho
  3. Benoit Delignat-Lavaud
  4. Constantin VL Delmas
  5. Priyabrata Halder
  6. Nicolas Giguère
  7. Consiglia Pacelli
  8. Sriparna Mukherjee
  9. Marie-Josée Bourque
  10. Martin Parent
  11. LuLu Y Chen  Is a corresponding author
  12. Louis-Eric Trudeau  Is a corresponding author
  1. Université de Montréal, Canada
  2. University of California, Irvine, United States
  3. University of Foggia, Italy
  4. Université Laval, Canada

Abstract

Midbrain dopamine (DA) neurons are key regulators of basal ganglia functions. The axonal domain of these neurons is highly complex, with a large subset of non-synaptic release sites and a smaller subset of synaptic terminals from which in addition to DA, glutamate or GABA are also released. The molecular mechanisms regulating the connectivity of DA neurons and their neurochemical identity are unknown. An emerging literature suggests that neuroligins, trans-synaptic cell adhesion molecules, regulate both DA connectivity and neurotransmission. However, the contribution of their major interaction partners, neurexins (Nrxns) is unexplored. Here we tested the hypothesis that Nrxns regulate DA neuron neurotransmission. Mice with conditional deletion of all Nrxns in DA neurons (DAT::Nrxns KO) exhibited normal basic motor functions. However, they showed an impaired locomotor response to the psychostimulant amphetamine. In line with an alteration in DA neurotransmission, decreased levels of the membrane DA transporter (DAT) and increased levels of the vesicular monoamine transporter (VMAT2) were detected in the striatum of DAT::Nrxns KO mice, along with reduced activity-dependent DA release. Strikingly, electrophysiological recordings revealed an increase of GABA co-release from DA neuron axons in the striatum of these mice. Together, these findings suggest that Nrxns act as regulators of the functional connectivity of DA neurons.

Data availability

All primary data are provided in the source data files accompanying the manuscript.

Article and author information

Author details

  1. Charles Ducrot

    Department of Pharmacology and Physiology, Université de Montréal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  2. Gregory de Carvalho

    Department of Anatomy and Neurobiology, University of California, Irvine, Irvine, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9179-7697
  3. Benoit Delignat-Lavaud

    Department of Pharmacology and Physiology, Université de Montréal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  4. Constantin VL Delmas

    Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  5. Priyabrata Halder

    Department of Pharmacology and Physiology, Université de Montréal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  6. Nicolas Giguère

    Department of Pharmacology and Physiology, Université de Montréal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  7. Consiglia Pacelli

    Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4915-5823
  8. Sriparna Mukherjee

    Department of Pharmacology and Physiology, Université de Montréal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  9. Marie-Josée Bourque

    Department of Pharmacology and Physiology, Université de Montréal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  10. Martin Parent

    Department of Psychiatry and Neurosciences, Université Laval, Quebec City, Canada
    Competing interests
    The authors declare that no competing interests exist.
  11. LuLu Y Chen

    Department of Anatomy and Neurobiology, University of California, Irvine, Irvine, United States
    For correspondence
    chenly@uci.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8873-3481
  12. Louis-Eric Trudeau

    Department of Pharmacology and Physiology, Université de Montréal, Montreal, Canada
    For correspondence
    louis-eric.trudeau@umontreal.ca
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4684-1377

Funding

Canadian Institutes of Health Research (MOP106556)

  • Louis-Eric Trudeau

University of California Irvine, School of Medicine (GF15247)

  • LuLu Y Chen

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All procedures involving animals and their care were conducted in accordance with the Guide to care and use of Experimental Animals of the Canadian Council on Animal Care. The experimental protocols (#21-113) were approved by the animal ethics committees of the Université de Montréal (CDEA).

Copyright

© 2023, Ducrot et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,300
    views
  • 260
    downloads
  • 5
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Charles Ducrot
  2. Gregory de Carvalho
  3. Benoit Delignat-Lavaud
  4. Constantin VL Delmas
  5. Priyabrata Halder
  6. Nicolas Giguère
  7. Consiglia Pacelli
  8. Sriparna Mukherjee
  9. Marie-Josée Bourque
  10. Martin Parent
  11. LuLu Y Chen
  12. Louis-Eric Trudeau
(2023)
Conditional deletion of neurexins dysregulates neurotransmission from dopamine neurons
eLife 12:e87902.
https://doi.org/10.7554/eLife.87902

Share this article

https://doi.org/10.7554/eLife.87902

Further reading

    1. Neuroscience
    Gergely F Turi, Sasa Teng ... Yueqing Peng
    Research Article

    Synchronous neuronal activity is organized into neuronal oscillations with various frequency and time domains across different brain areas and brain states. For example, hippocampal theta, gamma, and sharp wave oscillations are critical for memory formation and communication between hippocampal subareas and the cortex. In this study, we investigated the neuronal activity of the dentate gyrus (DG) with optical imaging tools during sleep-wake cycles in mice. We found that the activity of major glutamatergic cell populations in the DG is organized into infraslow oscillations (0.01–0.03 Hz) during NREM sleep. Although the DG is considered a sparsely active network during wakefulness, we found that 50% of granule cells and about 25% of mossy cells exhibit increased activity during NREM sleep, compared to that during wakefulness. Further experiments revealed that the infraslow oscillation in the DG was correlated with rhythmic serotonin release during sleep, which oscillates at the same frequency but in an opposite phase. Genetic manipulation of 5-HT receptors revealed that this neuromodulatory regulation is mediated by Htr1a receptors and the knockdown of these receptors leads to memory impairment. Together, our results provide novel mechanistic insights into how the 5-HT system can influence hippocampal activity patterns during sleep.

    1. Neuroscience
    Ulrike Pech, Jasper Janssens ... Patrik Verstreken
    Research Article

    The classical diagnosis of Parkinsonism is based on motor symptoms that are the consequence of nigrostriatal pathway dysfunction and reduced dopaminergic output. However, a decade prior to the emergence of motor issues, patients frequently experience non-motor symptoms, such as a reduced sense of smell (hyposmia). The cellular and molecular bases for these early defects remain enigmatic. To explore this, we developed a new collection of five fruit fly models of familial Parkinsonism and conducted single-cell RNA sequencing on young brains of these models. Interestingly, cholinergic projection neurons are the most vulnerable cells, and genes associated with presynaptic function are the most deregulated. Additional single nucleus sequencing of three specific brain regions of Parkinson’s disease patients confirms these findings. Indeed, the disturbances lead to early synaptic dysfunction, notably affecting cholinergic olfactory projection neurons crucial for olfactory function in flies. Correcting these defects specifically in olfactory cholinergic interneurons in flies or inducing cholinergic signaling in Parkinson mutant human induced dopaminergic neurons in vitro using nicotine, both rescue age-dependent dopaminergic neuron decline. Hence, our research uncovers that one of the earliest indicators of disease in five different models of familial Parkinsonism is synaptic dysfunction in higher-order cholinergic projection neurons and this contributes to the development of hyposmia. Furthermore, the shared pathways of synaptic failure in these cholinergic neurons ultimately contribute to dopaminergic dysfunction later in life.